• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT DIAGNOSTICS SCARBOROUGH, INC. BINAXNOW COVID-19 AG SELF TEST 2CT; CORONAVIRUS ANTIGEN DETECTION TEST SYSTEM.

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT DIAGNOSTICS SCARBOROUGH, INC. BINAXNOW COVID-19 AG SELF TEST 2CT; CORONAVIRUS ANTIGEN DETECTION TEST SYSTEM. Back to Search Results
Catalog Number 195-160
Device Problem Non Reproducible Results (4029)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 03/25/2023
Event Type  malfunction  
Manufacturer Narrative
Testing was performed at abbott diagnostics scarborough, inc.On retained kit lot 196077 with internal positive quality control samples and negative quality control swabs.All test results were valid and performed as expected.Additionally, the manufacturing records and quality control release testing was reviewed for kit part number 195-160/ lot 196077 and device part number 195-430h/ lot 191574.The lot met the required release specifications.A review of the complaints reported as false positive patient results (confirmed and unconfirmed, conflicting results) related to kit lot 196077 showed that the complaint rate is 0.000331%.A review of the complaints reported as false negative patient results (confirmed and unconfirmed, conflicting results) related to kit lot 196077 showed that the complaint rate is 0.000331%.Abbott diagnostics scarborough, inc.Was unable to determine the exact root cause of the reported issue, however, it could possibly be related to the specific patient sample.
 
Event Description
The consumer reported two (2) conflicting results with the binaxnow covid-19 antigen self-test for multiple tests performed on (b)(6) 2023 on a nasal sample.This mfr.Report addresses test two (2) of two (2).The consumer reported that the test generated a positive result when read at the fifteen (15) minute mark, but that the sample line disappeared before the thirty (30) minute mark.Confirmation testing was not performed.No additional patient information, including treatment and outcome, was provided.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BINAXNOW COVID-19 AG SELF TEST 2CT
Type of Device
CORONAVIRUS ANTIGEN DETECTION TEST SYSTEM.
Manufacturer (Section D)
ABBOTT DIAGNOSTICS SCARBOROUGH, INC.
10 southgate road
scarborough ME 04074
Manufacturer Contact
rachel blackwell
10 southgate road
scarborough, ME 04074
6613888803
MDR Report Key16683579
MDR Text Key312869791
Report Number1221359-2023-00577
Device Sequence Number1
Product Code QKP
UDI-Device Identifier00811877011408
UDI-Public00811877011408
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
EUA210264
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Consumer
Reporter Occupation Non-Healthcare Professional
Type of Report Initial
Report Date 04/05/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received04/05/2023
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Expiration Date01/16/2024
Device Catalogue Number195-160
Device Lot Number196077
Was Device Available for Evaluation? No
Date Manufacturer Received03/25/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Age27 YR
Patient SexMale
Patient Weight67 KG
Patient EthnicityNon Hispanic
Patient RaceWhite
-
-